Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.

Published in: British journal of pharmacology (2018)

Peripheral CB1 receptor blockade used as add-on treatment to ACE-inhibition reverses albuminuria, nephrin loss and inflammation in DM.

Keyphrases